LISA TEUNISSEN: Open Payments
NPI 1952966111 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 69 payments from 30 companies in 2025. Trend: 2023 $1,589 · 2024 $1,717 · 2025 $1,628
Food & beverage: $1,628
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $167 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Janssen Biotech, Inc. | 4 | $118 |
| GENZYME CORPORATION | 5 | $115 |
| Incyte Corporation | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| BeOne Medicines USA, Inc. | 3 | $80 |
| Daiichi Sankyo Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
Products named: KEYTRUDA, SARCLISA, RYBREVANT, JAKAFI, OPDIVO, FRUZAQLA, BRUKINSA, Odomzo.
Industry payments across MI — which companies pay providers there.
